Richard Kovacs to Cardiovascular Diseases
This is a "connection" page, showing publications Richard Kovacs has written about Cardiovascular Diseases.
Connection Strength
0.319
-
Big data from electronic health records for early and late translational cardiovascular research: challenges and potential. Eur Heart J. 2018 04 21; 39(16):1481-1495.
Score: 0.061
-
Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes. JAMA Cardiol. 2017 04 01; 2(4):370-380.
Score: 0.057
-
Taking a stand against air pollution - the impact on cardiovascular disease. Eur Heart J. 2021 Apr 14; 42(15):1460-1463.
Score: 0.038
-
Taking a Stand Against Air Pollution-The Impact on Cardiovascular Disease: A Joint Opinion From the World Heart Federation, American College of Cardiology, American Heart Association, and the European Society of Cardiology. Circulation. 2021 Apr 06; 143(14):e800-e804.
Score: 0.037
-
Taking a Stand Against Air Pollution-The Impact on Cardiovascular Disease: A Joint Opinion from the World Heart Federation, American College of Cardiology, American Heart Association, and the European Society of Cardiology. J Am Coll Cardiol. 2021 04 06; 77(13):1684-1688.
Score: 0.037
-
Taking a Stand Against Air Pollution - The Impact on Cardiovascular Disease: A Joint Opinion from the World Heart Federation, American College of Cardiology, American Heart Association, and the European Society of Cardiology. Glob Heart. 2021 01 28; 16(1):8.
Score: 0.037
-
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly. N Engl J Med. 2018 10 18; 379(16):1509-1518.
Score: 0.032
-
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet. 2011 Jun 25; 377(9784):2181-92.
Score: 0.019